Aspirin a Day Keeps Tuberculosis Away?

10:26 EDT 26 Mar 2019 | Genetic Engineering News

While not quite as straight forward as the title would suggest, investigators at the Centenary Institute in Sydney did find that a brand-new target for treating drug-resistant tuberculosis is sensitive to anti-platelet drugs such as aspirin. Tuberculosis (TB) is still a major public health threat worldwide, with 10 million cases in 2017 and 1.3 million […]

The post Aspirin a Day Keeps Tuberculosis Away? appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Aspirin a Day Keeps Tuberculosis Away?


More From BioPortfolio on "Aspirin a Day Keeps Tuberculosis Away?"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...